
Noble E. Jarrell
Examiner (ID: 13867, Phone: (571)272-9077 , Office: P/1625 )
| Most Active Art Unit | 1699 |
| Art Unit(s) | 1624, 1622, 1625, 1699, 1609, 1629 |
| Total Applications | 1459 |
| Issued Applications | 965 |
| Pending Applications | 172 |
| Abandoned Applications | 340 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6571703
[patent_doc_number] => 20100234599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-16
[patent_title] => 'METHOD FOR PREPARING ACID ADDITION SALTS OF POLYACIDIC BASIC COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/762111
[patent_app_country] => US
[patent_app_date] => 2010-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 11374
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20100234599.pdf
[firstpage_image] =>[orig_patent_app_number] => 12762111
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/762111 | Method for preparing acid addition salts of polyacidic basic compounds | Apr 15, 2010 | Issued |
Array
(
[id] => 6518864
[patent_doc_number] => 20100216987
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-26
[patent_title] => 'SYNTHESIS OF NATURALLY OCCURING ECTEINASCIDINS AND RELATED COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/758182
[patent_app_country] => US
[patent_app_date] => 2010-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42734
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20100216987.pdf
[firstpage_image] =>[orig_patent_app_number] => 12758182
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/758182 | Synthesis of naturally occuring ecteinascidins and related compounds | Apr 11, 2010 | Issued |
Array
(
[id] => 7778489
[patent_doc_number] => 20120040975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-16
[patent_title] => 'BRIDGED BICYCLIC HETEROCYCLE DERIVATIVES AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/260950
[patent_app_country] => US
[patent_app_date] => 2010-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28823
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20120040975.pdf
[firstpage_image] =>[orig_patent_app_number] => 13260950
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/260950 | BRIDGED BICYCLIC HETEROCYCLE DERIVATIVES AND METHODS OF USE THEREOF | Mar 31, 2010 | Abandoned |
Array
(
[id] => 6638046
[patent_doc_number] => 20100173913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => 'PYRIDO-AND PYRIMIDOPYRIMIDINE DERIVATIVES AS ANTI-PROLIFERATIVE AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/724203
[patent_app_country] => US
[patent_app_date] => 2010-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16939
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20100173913.pdf
[firstpage_image] =>[orig_patent_app_number] => 12724203
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/724203 | Pyrido-and pyrimidopyrimidine derivatives as anti-proliferative agents | Mar 14, 2010 | Issued |
Array
(
[id] => 6090381
[patent_doc_number] => 20110218153
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-08
[patent_title] => 'Topical Glutathione Formulations For Menopausal Skin'
[patent_app_type] => utility
[patent_app_number] => 12/718706
[patent_app_country] => US
[patent_app_date] => 2010-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3448
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0218/20110218153.pdf
[firstpage_image] =>[orig_patent_app_number] => 12718706
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/718706 | Topical glutathione formulations for menopausal skin | Mar 4, 2010 | Issued |
Array
(
[id] => 8685270
[patent_doc_number] => 20130053554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-28
[patent_title] => 'PREPARATION OF BLEACHING CATALYSTS'
[patent_app_type] => utility
[patent_app_number] => 13/582040
[patent_app_country] => US
[patent_app_date] => 2010-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6885
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13582040
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/582040 | Preparation of bleaching catalysts | Mar 2, 2010 | Issued |
Array
(
[id] => 6530067
[patent_doc_number] => 20100221217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-02
[patent_title] => 'THERAPEUTIC COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 12/713497
[patent_app_country] => US
[patent_app_date] => 2010-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15026
[patent_no_of_claims] => 86
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20100221217.pdf
[firstpage_image] =>[orig_patent_app_number] => 12713497
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/713497 | Therapeutic composition | Feb 25, 2010 | Issued |
Array
(
[id] => 8208963
[patent_doc_number] => 20120128628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-24
[patent_title] => 'COMBINATION OF A NUCLEOSIDE POLYMERASE INHIBITOR WITH A MACROCYCLIC PROTEASE INHIBITOR AND USE THEREOF IN THE TREATMENT OF HEPATITIS C, LIVER FIBROSIS AND IMPAIRED LIVER FUNCTION (as amended)'
[patent_app_type] => utility
[patent_app_number] => 13/203334
[patent_app_country] => US
[patent_app_date] => 2010-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15300
[patent_no_of_claims] => 87
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20120128628.pdf
[firstpage_image] =>[orig_patent_app_number] => 13203334
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/203334 | COMBINATION OF A NUCLEOSIDE POLYMERASE INHIBITOR WITH A MACROCYCLIC PROTEASE INHIBITOR AND USE THEREOF IN THE TREATMENT OF HEPATITIS C, LIVER FIBROSIS AND IMPAIRED LIVER FUNCTION (as amended) | Feb 25, 2010 | Abandoned |
Array
(
[id] => 9703930
[patent_doc_number] => 08828992
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-09
[patent_title] => 'Substituted azole derivatives, pharmaceutical composition containing the derivatives, and method for treating Parkinson\'s disease using the same'
[patent_app_type] => utility
[patent_app_number] => 13/202449
[patent_app_country] => US
[patent_app_date] => 2010-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29323
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13202449
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/202449 | Substituted azole derivatives, pharmaceutical composition containing the derivatives, and method for treating Parkinson's disease using the same | Feb 24, 2010 | Issued |
Array
(
[id] => 7744400
[patent_doc_number] => 20120022046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-26
[patent_title] => 'Thienopyridine Derivatives for the Treatment and Prevention of Dengue Virus Infections'
[patent_app_type] => utility
[patent_app_number] => 13/203351
[patent_app_country] => US
[patent_app_date] => 2010-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23959
[patent_no_of_claims] => 80
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20120022046.pdf
[firstpage_image] =>[orig_patent_app_number] => 13203351
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/203351 | Thienopyridine derivatives for the treatment and prevention of dengue virus infections | Feb 23, 2010 | Issued |
Array
(
[id] => 6536886
[patent_doc_number] => 20100204214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'HISTAMINE H3 INVERSE AGONISTS AND ANTAGONISTS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/704460
[patent_app_country] => US
[patent_app_date] => 2010-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 82087
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20100204214.pdf
[firstpage_image] =>[orig_patent_app_number] => 12704460
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/704460 | Histamine H3 inverse agonists and antagonists and methods of use thereof | Feb 10, 2010 | Issued |
Array
(
[id] => 6513841
[patent_doc_number] => 20100216699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-26
[patent_title] => 'SEMI-SYNTHETIC GLYCOPEPTIDES HAVING ANTIBACTERIAL ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 12/697967
[patent_app_country] => US
[patent_app_date] => 2010-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24191
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20100216699.pdf
[firstpage_image] =>[orig_patent_app_number] => 12697967
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/697967 | SEMI-SYNTHETIC GLYCOPEPTIDES HAVING ANTIBACTERIAL ACTIVITY | Jan 31, 2010 | Abandoned |
Array
(
[id] => 7487774
[patent_doc_number] => 20110251215
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2011-10-13
[patent_title] => 'MACROCYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/692078
[patent_app_country] => US
[patent_app_date] => 2010-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 71724
[patent_no_of_claims] => 80
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0251/20110251215.pdf
[firstpage_image] =>[orig_patent_app_number] => 12692078
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/692078 | Macrocyclic compounds and their use as kinase inhibitors | Jan 21, 2010 | Issued |
Array
(
[id] => 7487774
[patent_doc_number] => 20110251215
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2011-10-13
[patent_title] => 'MACROCYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/692078
[patent_app_country] => US
[patent_app_date] => 2010-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 71724
[patent_no_of_claims] => 80
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0251/20110251215.pdf
[firstpage_image] =>[orig_patent_app_number] => 12692078
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/692078 | Macrocyclic compounds and their use as kinase inhibitors | Jan 21, 2010 | Issued |
Array
(
[id] => 4451308
[patent_doc_number] => 07964632
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-21
[patent_title] => 'Methods of treatment using a prodrug of an excitatory amino acid'
[patent_app_type] => utility
[patent_app_number] => 12/688074
[patent_app_country] => US
[patent_app_date] => 2010-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48965
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/964/07964632.pdf
[firstpage_image] =>[orig_patent_app_number] => 12688074
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/688074 | Methods of treatment using a prodrug of an excitatory amino acid | Jan 14, 2010 | Issued |
Array
(
[id] => 9503569
[patent_doc_number] => 08741883
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-03
[patent_title] => 'Compounds and methods for the diagnosis and treatment of amyloid associated diseases'
[patent_app_type] => utility
[patent_app_number] => 12/687070
[patent_app_country] => US
[patent_app_date] => 2010-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 20970
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12687070
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/687070 | Compounds and methods for the diagnosis and treatment of amyloid associated diseases | Jan 12, 2010 | Issued |
Array
(
[id] => 6590629
[patent_doc_number] => 20100130482
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'DIAZABICYCLIC ARYL DERIVATIVES AS NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS'
[patent_app_type] => utility
[patent_app_number] => 12/652512
[patent_app_country] => US
[patent_app_date] => 2010-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12311
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20100130482.pdf
[firstpage_image] =>[orig_patent_app_number] => 12652512
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/652512 | DIAZABICYCLIC ARYL DERIVATIVES AS NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS | Jan 4, 2010 | Abandoned |
Array
(
[id] => 10635592
[patent_doc_number] => 09353082
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-31
[patent_title] => 'Pharmaceutical compounds'
[patent_app_type] => utility
[patent_app_number] => 13/141205
[patent_app_country] => US
[patent_app_date] => 2009-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 120788
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13141205
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/141205 | Pharmaceutical compounds | Dec 22, 2009 | Issued |
Array
(
[id] => 7501752
[patent_doc_number] => 20110263608
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => '16-KETO ASPERGILLIMIDES AND HARMFUL ORGANISM CONTROL AGENT COMPRISING THE SAME AS ACTIVE INGREDIENT'
[patent_app_type] => utility
[patent_app_number] => 13/140625
[patent_app_country] => US
[patent_app_date] => 2009-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10651
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20110263608.pdf
[firstpage_image] =>[orig_patent_app_number] => 13140625
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/140625 | 16-KETO ASPERGILLIMIDES AND HARMFUL ORGANISM CONTROL AGENT COMPRISING THE SAME AS ACTIVE INGREDIENT | Dec 20, 2009 | Abandoned |
Array
(
[id] => 6637232
[patent_doc_number] => 20100173847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => 'TFPI INHIBITORS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 12/643818
[patent_app_country] => US
[patent_app_date] => 2009-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 179
[patent_figures_cnt] => 179
[patent_no_of_words] => 27620
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20100173847.pdf
[firstpage_image] =>[orig_patent_app_number] => 12643818
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/643818 | TFPI inhibitors and methods of use | Dec 20, 2009 | Issued |